Literature DB >> 11396610

Syntaxin 1A up-regulates GABA transporter expression by subcellular redistribution.

N Horton1, M W Quick.   

Abstract

Neurotransmitter transporters are regulated through a variety of signal transduction mechanisms which appear to operate in order to maintain appropriate levels of transmitter in the synaptic cleft. One such mechanism is the trafficking of the transporter in association with synaptic vesicle release machinery. This report examines the specifics of trafficking regulation of the rat brain GABA transporter GAT1 by syntaxin 1A, a plasma membrane component of the SNARE complex which is involved in vesicle membrane fusion. In hippocampal neurons, botulinum neurotoxin 1C, which specifically cleaves syntaxin 1A, down-regulates plasma membrane GAT1 levels as assessed by surface biotinylation, suggesting that syntaxin 1A is a positive regulator of GAT1 surface expression. The up-regulation correlates with a decrease in intracellular GAT1 levels and is complete within several minutes. These data suggest that syntaxin 1A mediates the redistribution of GAT1 on a time scale important for the rapid regulation of extracellular GABA levels. Expression of different syntaxin 1A constructs in Xenopus oocytes suggests that several portions of the syntaxin 1A molecule are required for the trafficking of GAT1. These data suggest that the trafficking of GAT1 will be subject to regulatory control by the many molecules known to interact with various domains of syntaxin 1A.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11396610

Source DB:  PubMed          Journal:  Mol Membr Biol        ISSN: 0968-7688            Impact factor:   2.857


  17 in total

1.  Substrates regulate gamma-aminobutyric acid transporters in a syntaxin 1A-dependent manner.

Authors:  Michael W Quick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Syntaxin 1A regulates surface expression of beta-cell ATP-sensitive potassium channels.

Authors:  Pei-Chun Chen; Cathrin E Bruederle; Herbert Y Gaisano; Show-Ling Shyng
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-05       Impact factor: 4.249

3.  Calpain sensitive regions in the N-terminal cytoplasmic domains of glycine transporters GlyT1A and GlyT1B.

Authors:  Martina Baliova; Frantisek Jursky
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

Review 4.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 5.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

6.  The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter.

Authors:  Ana M Carneiro; Susan L Ingram; Jean-Martin Beaulieu; Ava Sweeney; Susan G Amara; Sheila M Thomas; Marc G Caron; Gonzalo E Torres
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

7.  Syntaxin 1A regulation of weakly inactivating N-type Ca2+ channels.

Authors:  Joyce H Hurley; Anne L Cahill; Meijing Wang; Aaron P Fox
Journal:  J Physiol       Date:  2004-08-19       Impact factor: 5.182

8.  Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent.

Authors:  Ekaterina Boudanova; Deanna M Navaroli; Haley E Melikian
Journal:  Neuropharmacology       Date:  2007-11-22       Impact factor: 5.250

9.  Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.

Authors:  Francesca Binda; Concetta Dipace; Erica Bowton; Sabrina D Robertson; Brandon J Lute; Jacob U Fog; Minjia Zhang; Namita Sen; Roger J Colbran; Margaret E Gnegy; Ulrik Gether; Jonathan A Javitch; Kevin Erreger; Aurelio Galli
Journal:  Mol Pharmacol       Date:  2008-07-10       Impact factor: 4.436

Review 10.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.